SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Israel’s tech exports hit a record but foreign owners are claiming more of the gains

Full list of Israeli high-tech funding rounds in 2026

Sayeret Matkal veterans raise $22 million to teach the world English with AI

SentinelOne CEO sells $2.29 million in shares as stock closes in on its yearly high

Buzz

Most popular

Daily

Weekly

1

Buildots raises $130 million at nearly $1 billion valuation as AI boom drives data center construction

2

How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit

3

Oracle’s AI transformation gets more expensive as layoffs continue

4

OpenAI acquires Israeli-founded camera startup Glass Imaging for over $300 million

5

Oracle begins another round of layoffs as $2.8 billion restructuring plan expands

Divestment

7 stories about Divestment

אוסלו נורווגיה נורבגיה קרן העושר

Norwegian wealth fund divests from Israel’s banking sector

Four largest banks targeted for financing settlements; Caterpillar shares also sold.

הפגנה מפגינים פיטורים טבע אשדוד

With No Buyers, Teva to Close Israeli Medical Equipment Plant

09.04.18|Dror Reich

The facility in Ashdod is one of five Teva intends to sell or close in its home country

Allergan to Sell Teva Shares to J.P. Morgan

14.11.17|Dror Reich and Lilach Baumer

Allergan announced it pledged its 9.8% stake in Teva to J.P. Morgan as collateral, as part of a loan agreement. The company already agreed to sell a quarter of the stock in the first quarter of 2018

מטה טבע פתח תקווה

Teva Offloads Holdings in Australia’s Mesoblast

25.10.17|Dror Reich and Lilach Baumer

The stem-cell therapy company diluted Teva’s shares through a new offering in August

Founding Family Sells Holdings in Online Gambling Company 888

09.10.17|Golan Hazani and Lilach Baumer

Co-founder Aaron Shaked’s heirs sold their entire stake for nearly $300 million

חברת ה תרופות טבע Teva

Teva Sells Remaining Women's Health Assets

18.09.17|Lilach Baumer

After selling its Paragard business for $1.1 billion last week, Teva's remaining Women's Health business will be split between CVC Capital Partners and Foundation Consumer Healthcare in a $1.38 billion cash deal

מפעל חברת טבע הר חוצבים ירושלים

Teva Negotiating Sale of Remaining Women's Health Assets, Report Says

14.09.17|Lilach Baumer

CVC Capital Partners is nearing a $800 million deal for Teva's remaining Women's Health business, Bloomberg reported Thursday